SCHEMBL7924319

SCHEMBL7924319

O=C(O)CCCCCC(=O)Nc1ccccc1NC(=O)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.67
EPHX2 P34913 1/20 0.50
SOAT1 P35610 2/20 0.45
HDAC3 O15379 6/20 0.43
HDAC1 Q13547 6/20 0.43
HDAC2 Q92769 6/20 0.43
HDAC4 P56524 5/20 0.43
HDAC7 Q8WUI4 5/20 0.43
HDAC10 Q969S8 5/20 0.43
HDAC11 Q96DB2 5/20 0.43
HDAC8 Q9BY41 5/20 0.43
HDAC6 Q9UBN7 5/20 0.43
HDAC9 Q9UKV0 5/20 0.43
HDAC5 Q9UQL6 5/20 0.43
CASP3 P42574 2/20 0.43
NCOR2 Q9Y618 2/20 0.43
FABP7 O15540 1/20 0.41
FABP5 Q01469 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8696511 0.84 KMT2A (0.61) KMT2AEPHX2CASP3FABP7FABP5
SCHEMBL8046428 0.81 KMT2A (0.91) KMT2AEPHX2HDAC3HDAC1HDAC2
SCHEMBL17599913 0.81 KMT2A (0.91) KMT2AEPHX2HDAC3HDAC1HDAC2
SCHEMBL7932753 0.81 HDAC3 (0.47) KMT2AEPHX2SOAT1HDAC3HDAC1
SCHEMBL7103716 0.81 KMT2A (0.68) KMT2AEPHX2CASP3FABP7FABP5
SCHEMBL178761 0.81 KMT2A (1.00) KMT2AEPHX2CASP3FABP7FABP5
SCHEMBL178759 0.81 KMT2A (1.00) KMT2AEPHX2CASP3FABP7FABP5
SCHEMBL178760 0.81 KMT2A (1.00) KMT2AEPHX2CASP3FABP7FABP5
SCHEMBL17746959 0.81 KMT2A (1.00) KMT2AEPHX2CASP3FABP7FABP5
SCHEMBL178758 0.81 KMT2A (1.00) KMT2AEPHX2CASP3FABP7FABP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010028193-A1 COMPOUNDS INCLUDING PIMELIC ACID DERIVATIVES AS HDAC INHIBITORS REPLIGEN CORPORATION (US) 2010-03-11 WO disclosed